Search for: "MCNEIL V US" Results 261 - 280 of 375
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2010, 4:58 pm
(Patent Docs) Levaquin (Levofloxacin) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
7 May 2010, 11:11 am
The patents go to fan blades used in jet aircraft. [read post]
12 Apr 2010, 1:58 pm by MacIsaac
Examples of such cases are Fellowes, McNeil v. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of… [read post]
3 Apr 2010, 4:02 pm
Where an ad is literally false, the court has the power enjoin the use without reference to the impact of the ad on the buying public (McNeil-PCC v Bristol-Myers Squibb)(1991)). [read post]
5 Mar 2010, 9:10 pm
Cir. 2007); see also Ortho-McNeil Pharm., Inc. v. [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory… [read post]